← Back to Analyst Consensus 
LEXX Buy
Lexaria Bioscience Corp.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Dec 26, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $1.5 | 44% |
| Jul 29, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Jul 1, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Jan 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Dec 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Nov 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jul 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jul 10, 2024 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Mar 5, 2024 | Maxim Group | maintain | Buy → Buy | $12 | 42% |
| Jul 21, 2023 | Maxim Group | initiate | — → Buy | $2 | 42% |
Price Target Trend
Apr 24, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days